Cargando…

A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study

OBJECTIVES: Identifying prognostic factors helps optimize the treatment regimen and promote favorable outcomes. We conducted a prospective cohort study on patients with pulmonary tuberculosis to construct a clinical indicator-based model and estimate its performance. METHODS: We performed a two-stag...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Mengyao, Xue, Hao, Wang, Yuting, Wu, Zhuchao, Wen, Qin, Shi, Xinling, Wang, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940065/
https://www.ncbi.nlm.nih.gov/pubmed/36803117
http://dx.doi.org/10.1186/s12879-023-08053-x
_version_ 1784891000046485504
author Zhan, Mengyao
Xue, Hao
Wang, Yuting
Wu, Zhuchao
Wen, Qin
Shi, Xinling
Wang, Jianming
author_facet Zhan, Mengyao
Xue, Hao
Wang, Yuting
Wu, Zhuchao
Wen, Qin
Shi, Xinling
Wang, Jianming
author_sort Zhan, Mengyao
collection PubMed
description OBJECTIVES: Identifying prognostic factors helps optimize the treatment regimen and promote favorable outcomes. We conducted a prospective cohort study on patients with pulmonary tuberculosis to construct a clinical indicator-based model and estimate its performance. METHODS: We performed a two-stage study by recruiting 346 pulmonary tuberculosis patients diagnosed between 2016 and 2018 in Dafeng city as the training cohort and 132 patients diagnosed between 2018 and 2019 in Nanjing city as the external validation population. We generated a risk score based on blood and biochemistry examination indicators by the least absolute shrinkage and selection operator (LASSO) Cox regression. Univariate and multivariate Cox regression models were used to assess the risk score, and the strength of association was expressed as the hazard ratio (HR) and 95% confidence interval (CI). We plotted the receiver operating characteristic (ROC) curve and calculated the area under the curve (AUC). Internal validation was conducted by 10-fold cross-validation. RESULTS: Ten significant indicators (PLT, PCV, LYMPH, MONO%, NEUT, NEUT%, TBTL, ALT, UA, and Cys-C) were selected to generate the risk score. Clinical indicator-based score (HR: 10.018, 95% CI: 4.904–20.468, P < 0.001), symptom-based score (HR: 1.356, 95% CI: 1.079–1.704, P = 0.009), pulmonary cavity (HR: 0.242, 95% CI: 0.087–0.674, P = 0.007), treatment history (HR: 2.810, 95% CI: 1.137–6.948, P = 0.025), and tobacco smoking (HR: 2.499, 95% CI: 1.097–5.691, P = 0.029) were significantly related to the treatment outcomes. The AUC was 0.766 (95% CI: 0.649–0.863) in the training cohort and 0.796 (95% CI: 0.630–0.928) in the validation dataset. CONCLUSION: In addition to the traditional predictive factors, the clinical indicator-based risk score determined in this study has a good prediction effect on the prognosis of tuberculosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08053-x.
format Online
Article
Text
id pubmed-9940065
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99400652023-02-21 A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study Zhan, Mengyao Xue, Hao Wang, Yuting Wu, Zhuchao Wen, Qin Shi, Xinling Wang, Jianming BMC Infect Dis Research OBJECTIVES: Identifying prognostic factors helps optimize the treatment regimen and promote favorable outcomes. We conducted a prospective cohort study on patients with pulmonary tuberculosis to construct a clinical indicator-based model and estimate its performance. METHODS: We performed a two-stage study by recruiting 346 pulmonary tuberculosis patients diagnosed between 2016 and 2018 in Dafeng city as the training cohort and 132 patients diagnosed between 2018 and 2019 in Nanjing city as the external validation population. We generated a risk score based on blood and biochemistry examination indicators by the least absolute shrinkage and selection operator (LASSO) Cox regression. Univariate and multivariate Cox regression models were used to assess the risk score, and the strength of association was expressed as the hazard ratio (HR) and 95% confidence interval (CI). We plotted the receiver operating characteristic (ROC) curve and calculated the area under the curve (AUC). Internal validation was conducted by 10-fold cross-validation. RESULTS: Ten significant indicators (PLT, PCV, LYMPH, MONO%, NEUT, NEUT%, TBTL, ALT, UA, and Cys-C) were selected to generate the risk score. Clinical indicator-based score (HR: 10.018, 95% CI: 4.904–20.468, P < 0.001), symptom-based score (HR: 1.356, 95% CI: 1.079–1.704, P = 0.009), pulmonary cavity (HR: 0.242, 95% CI: 0.087–0.674, P = 0.007), treatment history (HR: 2.810, 95% CI: 1.137–6.948, P = 0.025), and tobacco smoking (HR: 2.499, 95% CI: 1.097–5.691, P = 0.029) were significantly related to the treatment outcomes. The AUC was 0.766 (95% CI: 0.649–0.863) in the training cohort and 0.796 (95% CI: 0.630–0.928) in the validation dataset. CONCLUSION: In addition to the traditional predictive factors, the clinical indicator-based risk score determined in this study has a good prediction effect on the prognosis of tuberculosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08053-x. BioMed Central 2023-02-20 /pmc/articles/PMC9940065/ /pubmed/36803117 http://dx.doi.org/10.1186/s12879-023-08053-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhan, Mengyao
Xue, Hao
Wang, Yuting
Wu, Zhuchao
Wen, Qin
Shi, Xinling
Wang, Jianming
A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study
title A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study
title_full A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study
title_fullStr A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study
title_full_unstemmed A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study
title_short A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study
title_sort clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940065/
https://www.ncbi.nlm.nih.gov/pubmed/36803117
http://dx.doi.org/10.1186/s12879-023-08053-x
work_keys_str_mv AT zhanmengyao aclinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy
AT xuehao aclinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy
AT wangyuting aclinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy
AT wuzhuchao aclinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy
AT wenqin aclinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy
AT shixinling aclinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy
AT wangjianming aclinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy
AT zhanmengyao clinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy
AT xuehao clinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy
AT wangyuting clinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy
AT wuzhuchao clinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy
AT wenqin clinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy
AT shixinling clinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy
AT wangjianming clinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy